Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Kleanthous

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Vaccine|May 25, 2019
Deciphering the domain specificity of C. difficile toxin neutralizing antibodiesLeah E Cole, Lu Li, Utsav Jetley, et al.
Journal of Virology|December 13, 2019
Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological BreadthYu Qiu, Svetlana Stegalkina, Jianxin Zhang, et al.
NPJ Vaccines|October 25, 2023
Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variantsNidhi Mittal, Sahil Kumar, Raju S Rajmani, et al.
Immunity|November 12, 2022
Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopesChengcheng Fan, Alexander A Cohen, Miso Park, et al.
Plos One|November 2, 2017
Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strainsIvette A Nuñez, Michael A Carlock, James D Allen, et al.
Human Vaccines & Immunotherapeutics|June 6, 2022
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvantsSakshi Bajoria, Kawaljit Kaur, Ozan S Kumru, et al.
NPJ Vaccines|January 20, 2024
Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, et al.
NPJ Vaccines|February 23, 2023
Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaquesCatherine Jacob-Dolan, Jingyou Yu, Katherine McMahan, et al.
The Journal of Clinical Investigation|July 1, 2021
Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycansJiwon Jung, Sophia T Mundle, Irina V Ustyugova, et al.
Science Translational Medicine|October 20, 2017
A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B virusesChenguang Shen, Junyu Chen, Rui Li, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Vaccine|May 25, 2019
Deciphering the domain specificity of C. difficile toxin neutralizing antibodiesLeah E Cole, Lu Li, Utsav Jetley, et al.
Journal of Virology|December 13, 2019
Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological BreadthYu Qiu, Svetlana Stegalkina, Jianxin Zhang, et al.
NPJ Vaccines|October 25, 2023
Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variantsNidhi Mittal, Sahil Kumar, Raju S Rajmani, et al.
Immunity|November 12, 2022
Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopesChengcheng Fan, Alexander A Cohen, Miso Park, et al.
Plos One|November 2, 2017
Impact of age and pre-existing influenza immune responses in humans receiving split inactivated influenza vaccine on the induction of the breadth of antibodies to influenza A strainsIvette A Nuñez, Michael A Carlock, James D Allen, et al.
Human Vaccines & Immunotherapeutics|June 6, 2022
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvantsSakshi Bajoria, Kawaljit Kaur, Ozan S Kumru, et al.
NPJ Vaccines|January 20, 2024
Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-CoV-2Klara Lenart, Rodrigo Arcoverde Cerveira, Fredrika Hellgren, et al.
NPJ Vaccines|February 23, 2023
Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaquesCatherine Jacob-Dolan, Jingyou Yu, Katherine McMahan, et al.
The Journal of Clinical Investigation|July 1, 2021
Influenza vaccination in the elderly boosts antibodies against conserved viral proteins and egg-produced glycansJiwon Jung, Sophia T Mundle, Irina V Ustyugova, et al.
Science Translational Medicine|October 20, 2017
A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B virusesChenguang Shen, Junyu Chen, Rui Li, et al.
Pageof 6